简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2018-12-19 16:02 Tilray® Signs Global Collaboration Agreement with Leading Pharmaceutical Company
2018-12-18 18:49 Brightree Acquires Mobile Delivery Provider Apacheta to Streamline HME Delivery
2018-12-18 16:32 Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD
2018-12-18 16:22 Fuji Pharma Invests in Alvotech for US$50 Million
2018-12-18 13:05 Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules
2018-12-14 18:35 Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer
2018-12-14 14:16 Tilray® Announces International Advisory Board
2018-12-14 13:43 Takeda and the New York Academy of Sciences Announce 2019 Innovators in Science Award Winners
2018-12-13 14:53 AMRA Receives U.S. FDA Clearance for AMRA® Profiler, a Magnetic Resonance Diagnostic Software Application Enabling Non-Invasive Evaluation of Body Composition
2018-12-12 10:12 Vitruvias Therapeutics Inc., Licenses Potassium Chloride ER ANDA (10 and 20 mEq) Capsules to Be Manufactured at Bora Pharmaceutical’s New Zhunan Facility in Taiwan
2018-12-11 15:07 China Shanghu Builds Itself into an International Health Demonstration Zone
2018-12-11 10:19 HEX Innovation Ltd. Signs an Agreement with UPHDMC, Philippines
2018-12-07 10:02 Brii Biosciences Builds Innovative Pipeline, Forges Public-Private Partnerships to Bring Novel Medicines to Chinese Patients
2018-12-06 17:39 Takeda Shareholders Approve Resolutions Related to the Proposed Acquisition of Shire plc
2018-12-06 12:34 Carnot BioSciences, a Spin off of SmartZyme BioPharma, and Hemoshear Therapeutics Partner to Develop Protein-Based Therapeutics for Rare Metabolic Diseases
2018-12-06 10:13 Seattle Genetics and Takeda Present Positive Data from Phase 3 ECHELON-2 Clinical Trial for ADCETRIS® (Brentuximab Vedotin) in Frontline Treatment of CD30-Expressing Peripheral T-Cell Lymphomas
2018-12-05 13:58 ResMed to Acquire Propeller Health, a Leader in COPD and Asthma Connected Health Solutions, for $225 Million
2018-12-04 18:30 Takeda Announces Execution of Loan Agreement in Connection with Proposed Acquisition of Shire plc
2018-12-04 16:46 Takeda to Present Positive Data from TOURMALINE-MM3, First Pivotal Phase 3 Placebo Controlled Trial Evaluating Proteasome Inhibitor Treatment in Maintenance Setting
2018-12-04 16:08 Tiziana Completes Patient Enrollment in a Phase 2a Trial to Evaluate Tolerability and Anti-Tumor Activity of Milciclib in Hepatocellular Carcinoma (HCC)

Business Wire Weibo

Press Releases

Latest Releases